A study to evaluate the usefulness of contrast medium 'Sonazoid; Perflubutane' in EUS diagnosis for pancreaticobiliary tumors.
Not Applicable
- Conditions
- pancreaticobiliary neoplastic lesions that require EUS
- Registration Number
- JPRN-UMIN000020395
- Lead Sponsor
- Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine. Kansai Medical University Hirakata Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Cases under 20 years old Cases without written informed consent Cases with allergy for Sonazoid; Perflubutane Cases with possibility of pregnant Cases considered ineligible for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method final diagnostic performance, pathological diagnostic accuracy
- Secondary Outcome Measures
Name Time Method